News & Updates
Filter by Specialty:
Show Multimedia Only
Tofacitinib safe, efficacious in ankylosing spondylitis regardless of baseline CRP
31 Aug 2024
byStephen Padilla
Tofacitinib demonstrates greater efficacy than placebo at week 12 in patients with ankylosing spondylitis (AS) regardless of their baseline C-reactive protein (CRP) levels, a study has shown.
Tofacitinib safe, efficacious in ankylosing spondylitis regardless of baseline CRP
31 Aug 2024
Steroid use may increase mortality in acute exacerbation of FILD
30 Aug 2024
byStephen Padilla
A high mortality risk hounds patients with acute exacerbation (AE) of fibrotic interstitial lung disease (FILD) despite treatment with corticosteroids, reports a study, noting that such risk is similar to that seen in those with AE of idiopathic pulmonary fibrosis (IPF).
